Inspire Medical Systems Retained Earnings (Accumulated Deficit) 2017-2025 | INSP
Inspire Medical Systems retained earnings (accumulated deficit) from 2017 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Inspire Medical Systems Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $-292 |
| 2023 | $-345 |
| 2022 | $-324 |
| 2021 | $-279 |
| 2020 | $-237 |
| 2019 | $-180 |
| 2018 | $-147 |
| 2017 | $-125 |
| 2016 | $0 |
| Inspire Medical Systems Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $-289 |
| 2024-12-31 | $-292 |
| 2024-09-30 | $-327 |
| 2024-06-30 | $-346 |
| 2024-03-31 | $-355 |
| 2023-12-31 | $-345 |
| 2023-09-30 | $-360 |
| 2023-06-30 | $-352 |
| 2023-03-31 | $-340 |
| 2022-12-31 | $-324 |
| 2022-09-30 | $-327 |
| 2022-06-30 | $-311 |
| 2022-03-31 | $-296 |
| 2021-12-31 | $-279 |
| 2021-09-30 | $-277 |
| 2021-06-30 | $-267 |
| 2021-03-31 | $-254 |
| 2020-12-31 | $-237 |
| 2020-09-30 | $-230 |
| 2020-06-30 | $-219 |
| 2020-03-31 | $-196 |
| 2019-12-31 | $-180 |
| 2019-09-30 | $-171 |
| 2019-06-30 | $-163 |
| 2019-03-31 | $-155 |
| 2018-12-31 | $-147 |
| 2018-09-30 | $-142 |
| 2018-06-30 | $-137 |
| 2018-03-31 | $-132 |
| 2017-12-31 | $-125 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.741B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.349B | 0.00 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.21 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |